Zobrazeno 1 - 10
of 740
pro vyhledávání: '"CARSTEN NIEDER"'
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-8 (2024)
Abstract Background Complex high-precision radiotherapy, such as stereotactic body radiotherapy (SBRT), should only be offered to patients with sufficiently long survival. In the context of bone metastases radiotherapy, low rates of treatment close t
Externí odkaz:
https://doaj.org/article/1122d4dd8fa546bd9c25a6057b2cb311
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-9 (2024)
Abstract Background This retrospective study analyzed the incidence of subsequent brain metastases after palliative radiotherapy or chemoradiation in patients with stage II/III non-small cell lung cancer (NSCLC). Risk factors for brain metastases dev
Externí odkaz:
https://doaj.org/article/de741a31c924434292a596c90fa26736
Publikováno v:
Contemporary Oncology, Vol 28, Iss 1, Pp 31-36 (2024)
Externí odkaz:
https://doaj.org/article/8a3135f21db745b59683026547659b6c
Publikováno v:
Contemporary Oncology, Vol 27, Iss 1, Pp 41-46 (2023)
Externí odkaz:
https://doaj.org/article/e67d78c4325c45a6ab95d20e3f268860
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background This study analyzed mortality after radiotherapy for bone metastases (287 courses). Endpoints such as treatment in the last month of life and death within 30, 35 and 40 days from start of radiotherapy were evaluated. Methods Diffe
Externí odkaz:
https://doaj.org/article/96e18b4084e64d83854307c72ae641b7
Autor:
Carsten Nieder, David McKenzie Grant
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 38, Iss , Pp 77-80 (2023)
Radiation to the carotid arteries, e.g. in the context of head and neck cancer treatment, is one of several risk factors for artery stenosis. In principle, this fact may also have implications for stereotactic cervical spine radiotherapy, because lon
Externí odkaz:
https://doaj.org/article/8b66cdfa231c46acbfc4ea3958b29a01
Publikováno v:
Current Oncology, Vol 29, Iss 10, Pp 7181-7188 (2022)
Background: Recently, graded prognostic assessment (GPA) for small cell lung cancer (SCLC) patients with brain metastases has been developed. This includes age, performance status, number of brain metastases and presence of extracranial metastases. T
Externí odkaz:
https://doaj.org/article/1ab1ec9021de42ffb744422b61e185af
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Biologically younger, fully independent octogenarians are able to tolerate most oncological treatments. Increasing frailty results in decreasing eligibility for certain treatments, e.g., chemotherapy and surgery. Most brain metastases are not an isol
Externí odkaz:
https://doaj.org/article/85ac26ebb70643e8ae8de6ad7f311095
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Background and objectivesThe validated LabBM score (laboratory parameters in patients with brain metastases) represents a widely applicable survival prediction model, which incorporates 5 blood test results (serum lactate dehydrogenase (LDH), C-react
Externí odkaz:
https://doaj.org/article/6504891eba78491d82808a0601812c2f
Autor:
Carsten Nieder, Luka Stanisavljevic, Siv Gyda Aanes, Bård Mannsåker, Ellinor Christin Haukland
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background Established prognostic models, such as the diagnosis-specific graded prognostic assessment, were not designed to specifically address very short survival. Therefore, a brain metastases-specific 30-day mortality model may be releva
Externí odkaz:
https://doaj.org/article/cb452cee49e04f038805799d7948366b